NYU Langone
- Adult & Family Medicine
- Oncology and Hematology
- Neurology & Neurosurgery
- Gastroenterology
- Cardiovascular
- Pulmonology
- Dermatology
- Endocrinology
- Events
Playback speed
10 seconds
A Personalized Cancer Vaccine mRNA-4157 + Pembro vs. Pembro in Resected HR-Melanoma: Efficacy & Safety Results From the Randomized, Open-Label Phase 2 mRNA-4157-P201/KEYNOTE-942 Trial
By
AACR 2023 Conference Coverage
FEATURING
Jeffrey Weber
By
AACR 2023 Conference Coverage
FEATURING
Jeffrey Weber
326 views
May 9, 2023
Login to view comments.
Click here to Login
Videos